دورية أكاديمية

Krónikus thromboemboliás pulmonalis hypertonia.

التفاصيل البيبلوغرافية
العنوان: Krónikus thromboemboliás pulmonalis hypertonia. (Hungarian)
العنوان البديل: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. (English)
المؤلفون: HAJNALKA, BÁLINT OLGA, PÉTER, ANDRÉKA
المصدر: Lege Artis Medicine (LAM); mar2024, Vol. 34 Issue 3, p97-100, 4p
مصطلحات موضوعية: PULMONARY hypertension diagnosis, THROMBOSIS surgery, HEART failure risk factors, PULMONARY embolism, TRANSLUMINAL angioplasty, PULMONARY artery, PULMONARY hypertension, SYNCOPE, BLOOD vessels, COMPUTED tomography, ENDARTERECTOMY, THROMBECTOMY, ECHOCARDIOGRAPHY, CARDIAC catheterization, DISEASE risk factors, DISEASE complications, SYMPTOMS
الملخص (بالإنجليزية): Chronic thromboembolic pulmonary hyper tension (CTEPH) is a vascular disease associated with pulmonary artery thrombosis, which causes changed flow patterns and remodeling of pulmonary blood vessels. CTEPH is a rare long-term complication of pulmonary embolism the cumulative incidence of which ranges between 0.1-9.1 in symptomatic patients. Early sign is the effort dyspnoea, later are dominating the right heart failure symptoms, and rarely the syncope. CTEPH should be suspected if there are emerging signs of chronic pulmonary artery thrombosis and echocardiography indicates symptoms of pulmonary hypertension. Demonstrating thrombosis V/Q scan, CT angiography or pulmonary angiography can be performed and in case of pulmonary hypertension right heart catheterisation. The modern approach to CTEPH treatment is a multimodality strategy. Pulmonary thromboendarterectomy is the first treatment of choice, but if the patient is not suitable for surgery, or he/she has chronic thromboembolic pulmonary hypertension, balloon pulmonary angioplasty and/or drug therapy should be considered. Treatment of chronic thromboembolic pulmonary hypertension patients is recommended in a CTEPH program center. [ABSTRACT FROM AUTHOR]
Abstract (Hungarian): A krónikus thromboemboliás pulmonalis hypertonia (chronic thromboembolic pulmonary hypertension, CTEPH) egy, a pulmonalis artériás thrombosishoz társuló vascularis betegség, amely az áramlási viszonyok megváltozásához és a pulmonalis erek másodlagos remodellingjéhez vezet. A CTEPH ritka hosszú távú szövôdménye a pulmonalis emboliának, melynek kumulatív incidenciája 0,1–9,1 között van tünetes betegekben. Korai tünetek az effort dyspnoe, késôbb a jobbszívfél-elégtelenség jelei dominálnak, ritkábban a syncope. CTEPH-ra kell gondolni, ha a krónikus pulmonalis artériás thrombosis lehetôsége felmerül és pulmonalis hypertonia jeleit látjuk echokardiográfiával. A thrombosis igazolására V/Q scant, CT-angiográfiát, illetve pulmonalis angiográfiát alkalmazunk, a pulmonalis hypertoniára pedig jobbszívfél-katéterezést. A CTEPH-kezelés modern szemlélete a multimodalitású terápia. Elsô válasz tandó terápia a pulmonalis thromboendarterectomia, ha a beteg nem alkalmas mûtétre, vagy residualis pulmonalis hypertoniája van, akkor ballonos pulmonalis angioplasztika, illetve gyógyszeres kezelés jön szóba. A krónikus thromboemboliás pul monalis hypertoniában szenvedô beteg kezelése CTEPH programmal rendelkezô centrumban javasolt. [ABSTRACT FROM AUTHOR]
Copyright of Lege Artis Medicine (LAM) is the property of LifeTime Media Kft. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:08664811
DOI:10.33616/lam.34.0097